| J9271 | Injection, pembrolizumab, 1 mg | 6,400 | $40 | $275.4K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 6,840 | $40 | $259.9K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 920 | $40 | $33.1K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 860 | $20 | $18.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 190 | $100 | $18.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $140 | $10.3K |
| Q5120 | Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg | 170 | $60 | $10.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 70 | $90 | $5.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 70 | $60 | $4.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 30 | $130 | $3.8K |